Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biochip Diagnoses Sepsis in Blood Samples

By LabMedica International staff writers
Posted on 28 Dec 2011
A new biochip will enable physicians to analyze blood for sepsis without having to send the sample to a central laboratory. More...


The more quickly and directly doctors recognize and treat sepsis, the greater the patient's chances of survival and speed can save lives especially in the case of blood poisoning.

A biochip device developed by scientists at the Fraunhofer Institute for Physical Measurement Techniques, (IPM; Freiburg, Germany) prepares the blood sample by separating the red blood cells from the blood and the plasma that remains is guided onto the biochip. In patients, who are suffering from sepsis, their immune system reacts by producing certain proteins. There are antibodies positioned on the chip, which fit these proteins as a key fits a lock. If the proteins are present in the blood, the antibodies fish them out of the fluid and bind them to the chip.

The apparatus distinguishes many tiny illuminated dots that show the protein was in the blood. If the patient is healthy, however, the chip remains dark. The scientists can even test for different proteins at the same time in one cycle. This is done by placing various different catcher molecules on the chip, to which specific molecules in the blood attach themselves. An ingenious selection of proven protein markers allows the investigators to obtain additional important information about the severity and cause of the illness.

Together with colleagues from a university hospital, the scientists have already successfully tested prototypes of the device and biochip. Each biochip can only be used once so they have to be affordable. Albrecht Brandenburg, PhD, a professor and group manager at IPM, said, "We predict that in the long run, with production on a large enough scale, each chip will cost no more than one euro. There are various possible applications: other conditions such as heart attacks or cancers can also be investigated in this way. What's more, the chip facilitates doping and urine testing."

Related Links:

Fraunhofer Institute for Physical Measurement Techniques



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.